Login / Signup

Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection.

Kevin ZhangPatricia BeckettSalaheddin AbouanaserMarek Smieja
Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2021)
Initial vancomycin was associated with a reduced rate of new incident infection in the treatment of adult inpatients with first-episode non-severe CDI. These findings support the use of initial vancomycin for all inpatients with CDI, when fidaxomicin is unavailable.
Keyphrases
  • clostridium difficile
  • methicillin resistant staphylococcus aureus
  • early onset
  • cardiovascular disease
  • staphylococcus aureus
  • young adults
  • replacement therapy